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Abstract
Introduction: Until now, studies on paracetamol given intravenously have mainly been performed with the pro-
drug propacetamol or with paracetamol in preterm babies above 32 weeks of gestation. Studies in these babies
indicate that intravenous paracetamol is tolerated well, however studies on the efficacy of intravenous paracetamol
are lacking. There are no pharmacokinetic data on the administration of multiple doses of paracetamol in preterm
babies with a gestational age below 32 weeks.
Case presentation: We present a case series of nine Caucasian preterm babies, six boys and three girls, with a
mean gestational age of 28.6 weeks (range 25.9 to 31.6 weeks). Case one, a girl with a gestational age of 25 weeks
and six days, presented with necrotizing enterocolitis. In the second case, a female baby with a gestational age of
26 weeks and two days presented with hematoma. In case three, a female baby with a gestation of 26 weeks and
one day developed intraventricular hemorrhage. In case four, a male baby with a gestational age of 31 weeks and
four days presented with pain after vacuum delivery. Case five, a female baby born after a gestation of 29 weeks
and six days presented with hematoma. In case six, a male baby with a gestation of 30 weeks and six days
presented with hematoma. In case seven, a male baby, born with a gestational age of 30 weeks and six days,
presented with caput succedaneum and hematoma. In case eight, a male baby, born after a gestation of 28 weeks
and four days, developed abdominal distention. Case nine, a female baby, born with a gestational age of 27 weeks
and three days presented with hematoma. These babies were treated with intravenous paracetamol 15 mg/kg
every six hours. Serum concentrations and aspartate transaminase were determined after prolonged administration.
Pain scores were assessed using the Premature Infant Pain Profile.
Conclusion: Paracetamol serum concentrations ranged from 8 to 64 mg/L after eight to 12 doses of intravenous
paracetamol. Adequate analgesia was obtained in seven babies. During paracetamol therapy the median serum
level of aspartate transaminase was 20 U/L (range 12 to 186 U/L). This case series indicates that prolonged
intravenous administration of paracetamol in preterm babies with a gestational age of less than 32 weeks is
tolerated well in the first days after birth. However, in the absence of proper pharmacokinetic data in this age
group we cannot advocate the use of paracetamol intravenously.
Introduction
Pain management in newborns is limited by the availabil-
ity of only a few analgesics. The use of opiates in new-
borns is limited because of potential clinical side effects.
As an alternative to opiates, paracetamol is a well-known
analgesic in children without significant side effects.
There are only limited data on the use of paracetamol in
the newborn. The first drafts of the evidence-based
guideline regarding pain management in children of the
Dutch Pediatric Society supported the intravenous
administration of paracetamol (15 mg/kg every six hours)
in babies. In advance of the guideline we introduced
intravenous administration of paracetamol to preterm
babies in our neonatal intensive care unit to reduce the
use of opiates. As a safety precaution we determined
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in babies with intravenous paracetamol.
After the release of the final version of the nationwide
evidence-based guideline on pain assessment and manage-
ment in children, it became clear that the guideline
restricted intravenous administration of paracetamol to
term babies after the first month [1]. After the release of
the final guideline we discontinued the local policy of
intravenous administration of paracetamol in preterm
babies. The Institutional Review Board/Independent Ethics
Committee was informed afterwards and concluded that
the presented data were obtained legally according the
Dutch Law on Medical Research with Humans (WMO).
Though the case series of nine is achieved in an unu-
sual manner, we consider the data on paracetamol levels
in preterm babies below 32 weeks of gestation as rele-
vant information for future clinical studies.
Case presentations
Case one
A Caucasian female baby was admitted to our NICU after
a gestation of 25 weeks and six days. Although delivery
started in the hospital the one minute Apgar score is not
available because no health care provider was present at
the time of birth. Her five minute Apgar score was six and
her birth weight was 890 grams (p50-75). During the third
week of life she developed necrotizing enterocolitis grade
one according to Bell’s criteria. She received 15 mg/kg
intravenous paracetamol every six hours, with a total of
four doses. Co-medications were antibiotics and ranitidine.
Pain score, as measured with the Premature Infant Pain
Profile (PIPP) decreased from 10 to eight (12 or more
reflects moderate to severe pain). After 24 hours paraceta-
mol was discontinued because of low PIPP scores. The
paracetamol serum level determined four hours after the
last dose was 24 mg/L.
Case two
A Caucasian female baby, born with a gestational age of 26
weeks and two days, was admitted with respiratory failure
to our NICU. She was intubated shortly after delivery.
Apgar scores were one and five after one and five minutes
respectively. Birth weight was 680 grams (p5-10). Because
of hematoma she received 15 mg/kg intravenous paraceta-
mol every six hours. Therapy was started four hours after
birth. She received a total of six doses. Pain scores
decreased from 10 to nine only. Co-medications were anti-
biotics and caffeine. The paracetamol serum level, which
was determined three hours after the last dose, was
29 mg/L.
Case three
A Caucasian female baby was admitted to our NICU
after a gestation of 26 weeks and one day. Shortly after
birth she developed respiratory failure and was intu-
bated. Apgar scores were one and five after one and five
minutes, respectively. Her birth weight was 800 grams
(p25-50). She developed a grade three intra-ventricular
hemorrhage for which morphine was started. Further
co-medications were antibiotics. In an attempt to stop
morphine, paracetamol was started, in a dose of 15 mg/
kg every six hours. Pain scores were below six during
morphine and remained so during paracetamol mono-
therapy. She received six doses of paracetamol and the
serum level was determined 20 hours after the last dose.
The serum level was 12 mg/L.
Case four
A Caucasian male baby, born with a gestational age of 31
weeks and four days, was admitted to our NICU after
vacuum delivery. Apgar scores were eight and nine after
one and five minutes, respectively. His birth weight was
1600 grams (p25-50). He received 15 mg/kg of intravenous
paracetamol every six hours for a total of eight doses. Pain
scores decreased from 14 before start of therapy to nine
during therapy. The paracetamol serum level was deter-
mined 10 hours after the last dose and was 25 mg/L.
Case five
A Caucasian female baby, born after a gestation of 29
weeks and six days, was admitted with hematoma due to
traumatic birth and breech delivery to our NICU. After
birth she received cardiopulmonary resuscitation because
of apnea and bradycardia. Apgar scores were one and six
after one and five minutes, respectively. Her birth weight
was 1300 grams (p25). She was diagnosed with hema-
toma and received 15 mg/kg of intravenous paracetamol
every six hours starting five hours after birth. She
received a total of nine doses of paracetamol. One hour
after the last dose her paracetamol serum level was
46 mg/L. Thirty hours later the serum level was deter-
mined again and was < 5 mg/L. Co-medications con-
sisted of antibiotics and caffeine. Pain scores decreased
from 16 before start of paracetamol to nine during
therapy.
Case six
A male Caucasian baby was admitted to our NICU after a
gestation of 30 weeks and six days. Birth took place in a
peripheral hospital and was complicated by breech presen-
tation and forceps delivery. Apgar scores were two and
seven after one and five minutes, respectively. Birth weight
was 1480 grams (p25). In the first hours of life he devel-
oped respiratory failure and was intubated. The baby
showed extensive hematoma for which 15 mg/kg of intra-
venous paracetamol every six hours was started. He
received a total of 10 doses. Three hours after the last dose
his paracetamol serum level was 64 mg/L. Co-medications
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10 before therapy to six during therapy.
Case seven
A Caucasian male baby, born with a gestational age of
30 weeks and six days, was admitted to our NICU after
an uneventful preterm delivery. The Apgar scores were
nine and 10 after one and five minutes, respectively. His
birth weight was 1755 gram (p50-75). He was diagnosed
with caput succedaneum and also had a small hema-
toma on one of the upper limbs. Due to high pain
scores he received 15 mg/kg of intravenous paracetamol
every six hours starting two hours after birth. He
received a total of 11 doses of paracetamol. His serum
paracetamol level was 37 mg/L four hours after the last
does. He received no co-medication. Pain scores
decreased from 14 before start of paracetamol to seven
during analgesic therapy.
Case eight
A Caucasian male baby, born after a gestation of 28
weeks and four days, was admitted with respiratory fail-
ure due to respiratory distress syndrome to our NICU.
Apgar scores were four and eight after one and five
minutes, respectively. His birth weight was 860 grams
(p25-50). He developed severe abdominal distention on
the second day of life and received 15 mg/kg of intrave-
nous paracetamol every six hours for a total of 14 doses.
There were no radiological signs of necrotizing entero-
colitis and his condition improved over the next few
days. Co-medications were antibiotics and caffeine. Five
hours after the last dose his paracetamol serum level
was 8 mg/L. Pain scores decreased from 14 before start-
ing paracetamol to three during therapy.
Case nine
A Caucasian female baby, born with a gestational age of
27 weeks and three days was admitted to our NICU
after preterm rupture of membranes and an uncompli-
cated delivery. Apgar scores were six and nine after one
and five minutes, respectively. Her birth weight was 990
gram (p50). Due to hematoma and subsequent high
pain scores (14) she received 15 mg/kg of intravenous
paracetamol every six hours. She received a total of 17
doses. Due to inadequate analgesic effect 10 μg/kg/hour
morphine was started during paracetamol therapy. Her
paracetamol serum level, determined seven hours after
the last dose, was 61 mg/L.
Table 1 summarizes the clinical data of the nine
babies.
Figure 1 shows the paracetamol serum concentrations
of the nine babies, related to the number of doses. In
seven babies the serum levels of paracetamol (the black
dots) are < 50 mg/l (grey area), the upper margin value
found by Palmer for babies > 32 weeks of gestation [2].
The highest serum concentration (64 mg/l) was far
below 150 mg/l (indicated by the dotted grey horizontal
line), which has been reported as a toxic value in chil-
dren [3].
Discussion
We administered intravenous paracetamol in a dose not
supported by literature. The dose we used in preterm
babies of less than 32 weeks gestation is being used in
term babies, and is not a result of miscalculation due to
the differences in formulations of propacetamol and
paracetamol [4].
Until now, most studies on intravenous paracetamol
have been performed with propacetamol in preterm
babies above 32 weeks of gestation. Propacetamol is a
pro-drug of paracetamol and is hydrolyzed by plasma
esterases after intravenous administration such that 1 g
of propacetamol is hydrolyzed to 0.5 g of paracetamol
[4-6]. To our knowledge this is the first report of para-
cetamol concentration data in preterm babies below 32
weeks of gestation, in whom multiple dose intravenous
paracetamol (Perfalgan
®) was administered for non-sur-
gical analgesia in the first hours after birth.
This case series indicates that in preterm babies below
32 weeks intravenous paracetamol is tolerated well. In
Table 1 Clinical data of the case series
Cases Gestational age
(wk)
Birth weight
(g)
Duration of
therapy (hr)
Start therapy (hr after
birth)
Interval last dose-blood
sample (hr)
Serum concentration
(mg/L)
1 25.9 890 24 408 4 24
2 26.4 680 36 4 3 29
3 26.1 800 36 72 20 12
4 31.6 1600 48 1 10 25
5 29.9 1300 54 5 1 46
6 30.9 1480 60 1 3 64
7 30.9 1755 66 2 4 37
8 28.6 860 84 37 5 8
9 27.4 990 102 1 7 61
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mg/l, the upper margin value reported by Palmer [2]. In
two subjects serum values were around 60 mg/l. During
paracetamol therapy we found no indications for liver
failure.
Although the therapeutic window for paracetamol in
children is assumed to be 10-20 mg/l, there is no con-
sensus on dosage regimens for intravenous administra-
tion of paracetamol in babies [7]. Allegaert, using
propacetamol, suggests a maintenance dose of 20 mg/kg
every 12 hours for babies below 31 weeks gestational
age after a loading dose of 30 mg/kg propacetamol [4].
Using this dose, Allegaert was not able to show signifi-
cant analgesic effect [5]. However, with a maintenance
dose of 12.5 mg/kg every six hours Allegaert showed
analgesic effects [6]. Autret suggests a maximum of 7.5
m g / k ge v e r y6h o u r sa f t e ral o a d i n gd o s eo f1 5m g / k g
propacetamol in newborns for antipyretic effects [8].
Autret did not study the analgesic effect. In term new-
borns, de la Pintière describes a maintenance dose of
intravenous propacetamol of 120 mg/kg/day, equivalent
to paracetamol 60 mg/kg/day [9].
Limited data is available concerning the pharmacoki-
netics of propacetamol and paracetamol [2,5,6,10]. Both
Allegaert and Palmer found serum levels of paracetamol
between < 6 and 50 mg/l, after a single dose of propace-
tamol and multiple doses of intravenous paracetamol,
respectively. Note that Palmer included preterm babies
above 32 weeks of gestation [2]. In a letter to the editor,
Bartocci et al report their Stockholm experience of post-
operative analgesia with intravenous morphine and para-
cetamol (maintenance dose 7.5 mg/kg every eight hours)
in newborns with a postconceptional age between 25
and 42 weeks [11]. From the letter, however, it is
unclear at what postnatal age paracetamol is given and
no paracetamol concentration data are shown.
Several cases report accidentally given overdoses of
propacetamol or paracetamol. Two doses of approxi-
mately 300 mg/kg propacetamol (equivalent to 150 mg/
kg paracetamol) at a 6 hour interval given to a term
baby, resulted in a serum level of 166 mg/l without
signs or symptoms of liver failure [9]. Two babies born
prematurely after maternal overdose of paracetamol had
s e r u mc o n c e n t r a t i o n so f7 6a n d2 6 0m g / lr e s p e c t i v e l y ,
without apparent adverse effects [12,13]. A paracetamol
overdose in a preterm baby resulted in a serum concen-
tration of 121 mg/l [14].
Recently, Bristol-Myers Squibb Pharmaceuticals Ltd
issued a letter with drug safety information concerning
accidental overdose in 23 world wide cases. All were
babies younger than one year, one of whom died. Scope
of the letter was a raising concern on the possible con-
fusion in prescribing ml/kg instead of mg/kg, leading to
a tenfold overdose [15]. The letter does not provide
information on serum levels or liver functions in these
cases.
Conclusion
This case series is not a formal pharmacokinetic study.
Obviously, the small sample size and the single serum
concentration limit a pharmacokinetic interpretation of
paracetamol therapy in preterm babies. Still, this case
series of nine very preterm babies indicates that parace-
tamol administration in a maintenance dose of 15 mg/
kg/day every six hours results in paracetamol concentra-
tions that are in the range of others [2,5,10]. It suggests
that intravenous paracetamol is tolerated well in the
first hours after birth in very preterm babies. However,
since proper pharmacokinetic data in this age group is
still lacking, we cannot advocate the use of paracetamol
intravenously based on our observations. It is obvious
that future studies should target determination of dosing
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Figure 1 Paracetamol serum levels in relation to number of doses. In seven babies the serum levels of paracetamol (the black dots) are <
50 mg/L (grey area), the upper margin value found by Palmer for babies > 32 weeks of gestation [2]. The highest serum concentration (64 mg/
L) was far below 150 mg/L (indicated by the dotted grey horizontal line), which has been reported as a toxic value in children [3].
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without adverse effects (tolerance) in newborns in the
first four weeks after birth.
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